Product Program year 2019 Source: CMS Open Payments

Prevnar - 13

Biological Vaccines

NDC 0005-1971-02

Open in the dashboard

General payments

$901,197

38,517 payments

Research payments

$25,997,681

2,879 payments

Through program year 2019, $901,197 in general payments and $25,997,681 in research payments were reported against Prevnar - 13 (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $901,197 38,517
2019 Research $25,997,681 2,879

Breakdown

Who paid General payments · program year 2019
  1. Pfizer Inc. $847,437 38,312 payments
  2. Pfizer Pharmaceuticals LLC $31,252 161 payments
  3. Pfizer International LLC $21,929 8 payments
  4. PBG Puerto Rico LLC $579 36 payments
Top recipients General payments · program year 2019
  1. Brett Gilbert Infectious Disease · Wynnewood, PA $51,329 6% · 66 payments
  2. Stephen Pelton Pediatric Infectious Diseases · Boston, MA $36,878 4% · 11 payments
  3. Luis Garcia Barreto Pulmonary Disease · Coamo, PR $24,226 3% · 38 payments
  4. Thomas Kaspar Infectious Disease · Victoria, TX $16,243 2% · 36 payments
  5. Elizabeth Race Infectious Disease · Dallas, TX $16,057 2% · 18 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Family Medicine $233,894 28% · 7,745 practitioners
  2. Internal Medicine $220,195 26% · 5,213 practitioners
  3. Infectious Disease Internal Medicine $137,181 16% · 110 practitioners
  4. Pediatrics $106,541 13% · 4,113 practitioners
  5. Pediatric Infectious Diseases Pediatrics $41,312 5% · 20 practitioners

The top 5 of 112 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Pennsylvania $84,324 9% · 809 recipients
  2. California $78,566 9% · 1,632 recipients
  3. Texas $74,635 8% · 1,490 recipients
  4. Florida $62,958 7% · 1,681 recipients
  5. Massachusetts $53,265 6% · 224 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

38,517 general · 2,879 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record